Directory · US
Biotechnology in United States
A register of firms and the professionals working at them in the Biotechnology sector based in United States. Browse the public index, then filter or export on Kipplo.
Companies
2.7K on file
Biotek Instruments
BioTek, now a part of Agilent Technologies, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. Our comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, stackers and pipetting systems. These products enable life science research by providing high performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications.
10001+ staff
Regeneron
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.
10001+ staff
Eurofins Genomics Americas
Eurofins Genomics provides the fastest high-quality products and services in the genomics industry- Synthetic DNA (oligonucleotides) with hundreds of modification options and record-setting turnaround time - Specialized long RNA oligos with a large variety of modifications available - Gene Synthesis for individual genes or complete libraries using codon optimization software - Sanger Sequencing with overnight results anywhere in the US- Nanopore Sequencing for whole plasmids, amplicons, and bacterial genome samples. Same day results. Impeccable quality. As part of the Eurofins Scientific group, the clients of Eurofins Genomics enjoy the power of over staff in around 180 laboratories across 35 countries. Eurofins Scientific is the world leader in food and bio/ pharma products testing. Many of its labs are found here in the US and throughout the Americas. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics, pharma discovery services, and central laboratory services.
10001+ staff
Axygen
Founded and incorporated in 1993, Axygen Scientific is the leading global supplier of laboratory plastics for the research industry, including the pharmaceutical, biotech, and academia markets. Axygen, Inc. is now a part of Corning Incorporated.
10001+ staff
Abclonal Technology
Based in Massachusetts, ABclonal is a dynamic and growing provider of biology research reagents and services. With scientists from world-class universities, we thrive to improve the quality of life science research by providing high-quality antibodies, proteins, ELISA kits, NGS Prep Kits and molecular enzymes. ABclonal has a comprehensive prokaryotic and eukaryotic protein expression system, advanced mouse monoclonal antibody production system and a fourth-generation rabbit monoclonal antibody technology. Our advanced technology allows the development of in vitro diagnostic products and customized IVD materials used in the early research and development of raw materials development services.#Biotechnology #LifeScience #Antibody #ResearchTools
501 to 1000 staff
Arcus Biosciences
Arcus Biosciences is a rapidly growing, clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines that may have the potential to help people with cancer live longer. Located in the San Francisco bay area, Arcus Biosciences offers a competitive compensation and benefits package, including aggressive participation in the growth of the company in the form of stock option grants. Arcus has an ambitious undertaking and expects to become a force in the discovery, development and commercialization of novel combination therapies to treat cancer in areas of high unmet need. Our employees enjoy operating in an exceptionally dynamic and team-driven environment in which the “rule book” has not yet been written.
501 to 1000 staff
Nektar Therapeutics
Since its inception, Nektar has led with scientific ingenuity, unwavering resilience and a bold commitment to improving patients’ lives. We have built expertise spanning foundational scientific research, cutting-edge therapeutic discovery, clinical development, strategic partnerships and commercialization – all in pursuit of opportunities to improve outcomes for people with immune-mediated disease. Through the years, we have developed a proven track record of translating groundbreaking research into innovative therapies in partnership with leading pharmaceutical companies. We remain focused on advancing scientific discoveries into safer, more effective treatments for people living with autoimmune diseases and inflammatory conditions.
51 to 200 staff
Vical
Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies and other therapeutic approaches. Headquartered in San Diego, CA, Vical is independently pioneering the development of paradigm-changing therapies, and is partnering with key industry leaders. Additional information on Vical is available at
11 to 50 staff
Adaptive Biotechnologies Corp
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Working with drug developers, clinicians and academic researchers, we are applying these insights to develop products that will transform the way diseases - such as cancer, autoimmune conditions, and infectious diseases - are diagnosed and treated. For more information, please visit adaptivebiotech.com.
501 to 1000 staff
Allogene Therapeutics
Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. For additional information on our guidelines, please visit Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at
201 to 500 staff
Atum
ATUM is an industry-leading provider of life science tools and solutions. Founded as DNA2.0 in 2003, we were a pioneer in the application of machine learning to synthetic biology and currently hold multiple patents covering several technologies, including our first-to-market Leap-In Transposase® platform. Our integrated offerings include Gene Design & Synthesis, Protein Production, and Cell Line Development — all powered by our Leap-In Transposase® and machine learning platform. This means a streamlined path from sequence to Research Cell Bank (RCB) with just a click, ensuring efficiency, regulatory compliance, and innovative solutions tailored to our clients' needs. ATUM is privately held and is headquartered in Newark, CA.
51 to 200 staff
Beta Bionics
Beta Bionics is a commercial stage medical technology company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWDs) by utilizing advanced adaptive algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared autonomous insulin delivery device in the market and offers the potential to substantially improve overall outcomes across broad populations of PWDs. To learn more, visit For safety information, visit:
201 to 500 staff
Biobridge Global
BioBridge Global, a San Antonio-based 501(c)(3) nonprofit, integrates donor-to-patient services to enable the future of biotherapeutic solutions, including blood, tissue and advanced therapies. Through its subsidiaries – South Texas Blood & Tissue, QualTex Laboratories and BBG Advanced Therapies – BioBridge Global provides products and services in blood resource management, cellular therapy manufacturing, donated umbilical cord blood and human tissue, as well as testing of blood, plasma, tissue and cellular products for clients in the United States and international markets. It supports the development of advanced therapies by providing access to starting materials, testing services, biomanufacturing and clinical trials support. BioBridge Global is committed to saving and enhancing lives through the healing power of human cells and tissue. Learn more at BioBridgeGlobal.org. You can also find us on Twitter at @BioBridgeGlobal.
501 to 1000 staff
Biofire Defense
BioFire Defense is a proud member of the bioMérieux family — we play a critical role in helping to make the world a healthier place. We are on a mission to Align Readiness across government agencies protecting us from biothreats and emerging infectious diseases. We execute our mission focused on purposeful innovation, advancing global health security, and delivering uncompressing quality to our partners in the U.S. government, military, and public health agencies. BioFire Defense empowers government agencies, first responders, and healthcare professionals with actionable biothreat detection and diagnostic intelligence — protecting health and ensuring readiness against evolving threats.
51 to 200 staff
Biolife Solutions, Inc
Preserving the Promise™ The human body can heal itself. Cell and gene therapies are designed to augment the patient’s ability to fight disease but only if the living cells behind those therapies remain viable and functional throughout the production processes. At BioLife Solutions, our mission is to protect the integrity of cells and provide trusted tools, services, and expertise that can enable our customers to advance the development and delivery of cell and gene therapies. We believe the future of cell and gene therapies hinges on the integrity of every single cell and we are here to preserve that promise. For more information, please visit and follow BioLife on LinkedIn, Facebook and X. We are a publicly traded company listed on the NASDAQ under the ticker symbol BLFS.
201 to 500 staff
Boston Heart Diagnostics
Boston Heart Diagnostics is transforming the treatment of cardiovascular disease by providing healthcare providers and their patients with novel, personalized diagnostics and reports and integrated customized lifestyle programs that have the power to change the way clinicians and patients communicate about disease and improve heart health. Boston Heart looks beyond the “good” and “bad” cholesterol assessment that conventional labs provide to give a more complete and individualized picture of heart health. Founded by renowned cardiovascular researchers and led by seasoned lab and diagnostic executives, Boston Heart is one of the fastest growing health companies in the country. For more information on Boston Heart Diagnostics, please visit Current Career Opportunities Visit our website for a complete list of career opportunities:
201 to 500 staff
C4 Therapeutics, Inc
C4 Therapeutics (C4T)(Nasdaq: is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes.
51 to 200 staff
Celularity Inc
Celularity, headquartered in Florham Park, N.J, is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and economics. Celularity’s innovative approach to cell therapy harnesses the unique therapeutic potential locked within the postpartum placenta. Through nature’s immunotherapy engine – the placenta – Celularity is leading the next evolution of cellular medicine with placenta-derived T cells, NK cells, and pluripotent stem cells to target unmet and underserved clinical needs in cancer, infectious and degenerative diseases. To learn more visit celularity.com.
51 to 200 staff
Champions Oncology, Inc
Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development. Using both in vitro to in vivo testing platforms companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios. From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges. At the core of our services is the Champions TumorGraft® (CTG) platform, a comprehensive, unique compendium of PDX models that preserve the biological characteristics of human tumors and are highly predictive of clinical outcomes. Services utilizing Champions TumorGrafts® PDX tumor models include evaluating tumor sensitivity/resistance to various single, combination, standard and novel chemotherapy agents, biomarker discovery and the identification of novel drug combinations. Champions TumorGraft® PDX models are procured through agreements our Clinical Collaboration Network, a series of renowned oncology institutions in the US and around the world, as well as through the company’s Personalized Oncology Solutions business. Personalized Oncology Solutions assist clinical oncologists by establishing and administering expert tumor panels for their patients to analyze medical records and test results, to assist in understanding conventional and experimental options and to identify and arrange for testing, analysis and study of the patients’ cancer tissues, as appropriate. Additionally, the company offers personalized PDX development, drug studies and genome sequencing, whereby physicians evaluate the effects of cancer drugs and understand the genetic makeup of each patient’s tumor, enabling them to better select treatment regimens.
201 to 500 staff
Dow Agrosciences
Dow AgroSciences was acquired by Corteva Agriscience. To see what’s new, visit Corteva Agriscience at
5001 to 10000 staff
Drugscan
Drugscan is a national toxicology and infectious disease testing laboratory that partners with organizations and providers to provide the critical testing they need for healthier lives and safer workplaces. Founded in 1985, Drugscan has more than 35 years of experience in toxicology testing via their CAP-and SAMSHA-certified laboratories. Drugscan is a leading pioneer in providing prescription drug and addiction monitoring, specialized drug testing, and workplace drug testing, screening and program management services to clients in 48 states. Drugscan also provides infectious disease testing services, including real-time PCR testing for COVID-19, through their ViraScan laboratory. Drugscan’s corporate office and state-of-the-art laboratories are in Horsham, PA.
51 to 200 staff
Germfree
Germfree provides controlled aseptic environments as well as primary and secondary containment to serve the rigorous demands of our clients. Our laboratory equipment, cleanrooms, cGMP facilities and biosafety labs deliver solutions across the complete life science spectrum.
51 to 200 staff
Ieh Laboratories And Consulting Group
IEH is an international lab & consulting services company, offering a comprehensive portfolio of lab testing services and consultation across multiple industries. IEH works with food production plants and manufacturers to ensure that the products released into our global supply are tested, safe, and in compliance with regulatory standards. Since 2001, IEH has expanded it's reach to service over 10 countries, with more than 100 locations covering the United States, Canada, Mexico, Germany, England, Austria, Poland, Netherlands, China, and Australia. Our lab services include but are not limited to food microbiology, analytical chemistry, allergen testing, GMO testing, authenticity testing, claim and forensic analysis, molecular epidemiology, and FDA detention. Our consulting team provides innovative and proven food safety solutions by designing and implementing testing programs to reduce risks associated with food production, and provides crisis management and regulatory support to our food partners.
1001 to 5000 staff
Indica Labs
Indica Labs is the global leader in AI-powered digital pathology software and services. Our flagship HALO® and HALO AI platform revolutionizes quantitative evaluation of whole slide images. HALO Link provides collaborative image management while HALO AP® and HALO AP Dx deliver enterprise digital pathology for primary diagnosis with regulatory clearances in multiple markets. Through a commitment to open pathology, performance, scalability, and ease-of-use, we help pharma companies, diagnostic labs, hospitals, research organizations, and Indica’s own Cloud and Pharma Services make discoveries and diagnoses that transform patient care and scientific discovery.
51 to 200 staff
